JANUMET XR

A-S Medication Solutions🇺🇸 United States

FDA Page

Effective Date: Jun 16, 2023
Approval ID: ed768466-bea6-4672-a599-a7ad3a2a2209
Products: 1 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use JANUMET XR safely and effectively. See full prescribing information for JANUMET XR. JANUMET XR (sitagliptin and metformin hydrochloride extended-release) tablets, for oral use Initial U.S. Approval: 2012

Quick Stats

Total Products1

Labelers2

Label Sections27

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.